CARLOS
SOLANO VERCET
CATEDRÁTICO/A DE UNIVERSIDAD
Cristina
Eguizabal Argaiz
Cristina Eguizabal Argaiz-rekin lankidetzan egindako argitalpenak (6)
2024
2023
-
Rationale for combined therapies in severe-to-critical COVID-19 patients
Frontiers in Immunology, Vol. 14
2022
-
Identifying SARS-CoV-2 ‘memory’ NK cells from COVID-19 convalescent donors for adoptive cell therapy
Immunology, Vol. 165, Núm. 2, pp. 234-249
2021
-
A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol
Trials, Vol. 22, Núm. 1
-
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)
EClinicalMedicine, Vol. 39
-
SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy
Frontiers in Cell and Developmental Biology, Vol. 9